Literature DB >> 4128444

Immunochemical analysis of the idiotypes of mouse myeloma proteins with specificity for levan or dextran.

M Weigert, W C Raschke, D Carson, M Cohn.   

Abstract

This paper deals solely with idiotypic determinants, the configurations of which are modified when the antibody bearing them interacts with its ligand. This phenomenon is measured as an inhibition of the reaction between anti-idiotype and idiotype. Two points are made: (a) The assay for ligand-modifiable determinants can be used to determine the "size" of the combining site. This is illustrated here with the anti-alpha(1 --> 6) dextran mouse myeloma immunoglobulin W3129. Whether the interaction between a homologous series of alpha(1 --> 6) oligosaccharide ligands and the combining site of W3129 is measured by inhibition of precipitation with alpha(1 --> 6) dextran (4) or of binding of W3129 to anti-W3129 idiotype, the finding is the same. The order of inhibition is isomaltohexaose = isomaltopentaose >> isomaltotetraose > isomaltotriose >>> isomaltose. The combining site is optimally complementary to isomaltopentaose. (b) Cross-idiotypic specificity is closely correlated with cross-combining specificity; the converse is not true. This is illustrated here with three groups of mouse myeloma immunoglobulin, each specific for alpha(1 --> 3) dextran, alpha(1 -->6) dextran, beta(2 --> 1) or beta(2 --> 6) levan. If a given anti-idiotypic serum cross-reacted with several myeloma proteins, they always had similar combining specificity. Thus the three proteins, J558, MOPC 104E, and UPC 102, which cross-react with anti-J558 have combining specificity for alpha(1 --> 3) dextran; cross-reacting W3082, UPC 61, and Y5476 have specificity for levan; and cross-reacting W3129 and W3434 have specificity for alpha(1 --> 6) dextran. This extends previous studies with proteins specific for phosphorylcholine (7) or gamma-globulin (8). As expected, the converse is not true, for proteins may have combining specificity for alpha(1 --> 6) dextran e.g. QUPC 52, or levan e.g. J606, UPC 10 and yet not carry the above-mentioned reference idiotypes. The correlation between cross-idiotypic and combining specificity breaks down when idiotypic determinants which are not modifiable by ligand are studied. The implications of this are pointed out since most investigations deal with ligand-nonmodifiable determinants.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4128444      PMCID: PMC2139518          DOI: 10.1084/jem.139.1.137

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  Individual Antigenic Specificity of Isolated Antibodies.

Authors:  H G Kunkel; M Mannik; R C Williams
Journal:  Science       Date:  1963-06-14       Impact factor: 47.728

2.  Similar idiotypic specificities in immunoglobulin fractions with different antibody functions or even without detectable antibody function.

Authors:  J Oudin; P A Cazenave
Journal:  Proc Natl Acad Sci U S A       Date:  1971-10       Impact factor: 11.205

3.  The use of affinity chromatography for the specific purification of antibodies and antigens.

Authors:  L Wofsy; B Burr
Journal:  J Immunol       Date:  1969-08       Impact factor: 5.422

4.  Immunochemical studies on mouse myeloma proteins with specificity for dextran or for levan.

Authors:  A Lundblad; R Steller; E A Kabat; J W Hirst; M G Weigert; M Cohn
Journal:  Immunochemistry       Date:  1972-05

5.  Genetics of the antibody response to dextran in mice.

Authors:  B Blomberg; W R Geckeler; M Weigert
Journal:  Science       Date:  1972-07-14       Impact factor: 47.728

6.  Cross-idiotypic specificity among monoclonal IgM proteins with anti- -globulin activity.

Authors:  H G Kunkel; V Agnello; F G Joslin; R J Winchester; J D Capra
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

7.  Immunochemical studies on mouse myeloma proteins reactive with dextrans or with fructosans and on human antilevans.

Authors:  J Cisar; E A Kabat; J Liao; M Potter
Journal:  J Exp Med       Date:  1974-01-01       Impact factor: 14.307

8.  Quantitative investigations of idiotypic antibodies. IV. Inhibition by specific haptens of the reaction of anti-hapten antibody with its anti-idiotypic antibody.

Authors:  B W Brient; A Nisonoff
Journal:  J Exp Med       Date:  1970-11       Impact factor: 14.307

9.  Common individual antigenic determinants in five of eight BALB-c IgA myeloma proteins that bind phosphoryl choline.

Authors:  M Potter; R Lieberman
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

10.  INDIVIDUAL ANTIGENIC SPECIFICITY OF MYELOMA PROTEINS. CHARACTERISTICS AND LOCALIZATION TO SUBUNITS.

Authors:  H M GREY; M MANNIK; H G KUNKEL
Journal:  J Exp Med       Date:  1965-04-01       Impact factor: 14.307

View more
  15 in total

1.  The V-region sequence of the H chain from a third rabbit anti-pneumococcal antibody.

Authors:  J C Jaton
Journal:  Biochem J       Date:  1976-08-01       Impact factor: 3.857

2.  A common idiotype on human macroglobulins with anti-I and anti-i specificity.

Authors:  J Lecomte; T Feizi
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

3.  Anti-hypervariable region antibody induced by a defined peptide: an approach for studying the structural correlates of idiotypes.

Authors:  P P Chen; R A Houghten; S Fong; G H Rhodes; T A Gilbertson; J H Vaughan; R A Lerner; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

4.  Structure of antibodies with shared idiotypy: the complete sequence of the heavy chain variable regions of two immunoglobulin M anti-gamma globulins.

Authors:  J D Capra; J M Kehoe
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

5.  Idiotypes and biological activity of murine monoclonal antibodies against the hemagglutinin of measles virus.

Authors:  J Gheuens; D E McFarlin; K W Rammohan; W J Bellini
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

6.  Nucleotide sequence of the cDNAs encoding the variable region heavy and light chains of a myeloma protein specific for the terminal nonreducing end of alpha(1----6)dextran.

Authors:  P Borden; E A Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

7.  Multiple individual and cross-specific indiotypes on 13 levan-binding myeloma proteins of BALB/c mice.

Authors:  R Lieberman; M Potter; W Humphrey; E B Mushinski; M Vrana
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

8.  Clonal nature of the immune response to phosphorylcholine. IV. Idiotypic uniformity of binding site-associated antigenic determinants among mouse antiphosphorylcholine antibodies.

Authors:  J L Claflin; J M Davie
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

9.  Immunochemical studies on mouse myeloma proteins reactive with dextrans or with fructosans and on human antilevans.

Authors:  J Cisar; E A Kabat; J Liao; M Potter
Journal:  J Exp Med       Date:  1974-01-01       Impact factor: 14.307

10.  Loss of an individual idiotype on chemical modification. A strategy for assigning idiotypic determinants.

Authors:  J Dickerman; B Clevinger; B Friedenson
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.